1. ALZHEIMER’S DISEASE -(AD) ANDITSHERBALTREATMENT Presented by---K.Swathi priya ( regd no.609209506005 )Under the esteemed guidance ofprof. Ganga rao Bottu . M.Pharm.,Ph.D.(…

1.Newer drugs in pipeline for Alzheimer's 2. Goal of Clinical Research are to SLOW or STOP disease progression and PREVENT Alzheimer's disease. So early diagnosis…

1. Huntington’s Disease:Autosomal dominant disorder characterized by progressive neurodegeneration, usually most pronounced in thebasal gangliaandcortex .Early symptoms…

1. DOI: 10.1126/science.1217697 , 1503 (2012);335Science et al.Paige E. Cramer Deficits in AD Mouse Models -Amyloid and ReverseβApoE-Directed Therapeutics Rapidly Clear…

ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT Presented by: Fariha Fatima JR-1 Department of Pharmacology INTRODUCTION:…

ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT ALZHEIMER’S DISEASE: PATHOPHYSIOLOGY AND TREATMENT Presented by: Fariha Fatima JR-1 Department of Pharmacology INTRODUCTION:…

National Institute on Aging National Institutes of Health ALZHEIMERâS DISEASE The Federal governmentâs lead agency for Alzheimerâs disease research is the National Institute…

* Bi / CNS 150 Lecture 23 Friday November 22, 2014 Neurodegenerative diseases Bruce Cohen Kandel, Chapters 43, 44 (p. 1002 - 1012), 59 Neurodegenerative Diseases Neurodegenerative…

National Institute on Aging National Institutes of Health ALZHEIMERâS DISEASE The Federal governmentâs lead agency for Alzheimerâs disease research is the National Institute…